Tufts CSDD R&D Cost Study
March 9, 2016: The R&D cost study has been published online in the Journal of Health Economics and will be available in print in May 2016. The citation for the journal article is as follows:
DiMasi JA, Grabowski HG, Hansen RA. Innovation in the pharmaceutical industry: new estimates of R&D costs. Journal of Health Economics 2016;47:20-33.
March 2, 2015: On February 3, 2015, Dr. Joseph DiMasi, lead economist for the Tufts Center for the Study of Drug Development's (CSDD) recently released study results on the R&D costs of new drug development, received a letter from the Union for Affordable Cancer Treatment (UACT) posing a series of questions about the study. The UACT letter, as well as Dr. DiMasi’s detailed response, are posted here.
Tufts CSDD remains committed to responding to questions about our cost study’s methodology and findings, and we welcome the opportunity to engage in a productive dialogue with all interested stakeholders regarding the study’s implications.
To view the letters, see the following links:
November 18, 2014: Cost Study Press Event Webcast:
Tufts CSDD recently hosted a briefing on Nov. 18, 2014 to present results of its latest study, updating the total average cost of developing and winning market approval for a new prescription drug. The following documents related to the study are available for download: